Niraparib 100mg tablets
NHS hospitals in England used £45,879,005 of indicative cost of Niraparib 100mg tablets in the 12 months to July 2026, about 0.2% of all hospital medicines spend. That is down 16.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Niraparib 100mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Niraparib 100mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Christie Nhs Foundation Trust | £2,718,804 |
| The Royal Marsden Nhs Foundation Trust | £2,149,795 |
| Southend Univ Hosp Nhs Foundation Trust | £1,860,750 |
| University College London Foundation Tr | £1,332,563 |
| South Tees Hosp Nhs Foundation Trust | £1,325,813 |
| Nottingham University Hospitals Trust | £1,319,786 |
| Derby Teaching Hospitals Nhs Found Trust | £1,244,250 |
| Royal Surrey County Hosp Nhs Found Trust | £1,192,500 |
| Hull And East Yorkshire Hpls Nhs Trust | £1,098,000 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £1,059,750 |
The primary-care picture
Niraparib is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Niraparib medicine page.